- Australian fertility service company Monash is restarting its IVF business in Victoria.
- The stock closed over 4% higher today.
- Victorian Minister of Health had announced a temporary ban on IVF procedures from 12 January to 12 April 2022.
The shares of ASX listed Monash IVF Group Ltd (ASX:MVF) have gained today after the Group updated on its IVF treatments.
The scrip closed 4.52% higher at AU$1.04 today.
The Victorian Minister of Health had previously announced a temporary ban on specific IVF procedures amid the COVID-19 outbreak from 12 January to 12 April 2022.
Today, the government said that IVF procedures will resume after the revisions to the non-urgent surgery setting were announced on January 12, 2022. According to the announcement, certain services will resume on January 20, 2022, with the remainder starting at 11.59 p.m. on Tuesday, January 25, 2022. As a result, the company's Victorian IVF business will reopen on January 26, 2022, with all services resumed. The Company's activities outside of Victoria are unaffected, and services continue to be supplied.
The company concentrates on informing patients about their options for resuming treatment and ensuring that enough staff and resources are available to satisfy demand.
MVE is committed to ensuring that proper safeguards and protocols are in place to protect the health and safety of its patients, employees, and specialists.